GLI1 and melanoma: Therefore, we decided to test these Hh inhibitors in vitro in order to target SMO and/or GLI1 and analyse melanoma migration and invasion to see if they could reduce this activity as a first step in developing new therapeutical strategies for melanoma treatment.